Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Information exchanges : Amex save search
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
Published: 2024-03-18 (Crawled : 16:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: -0.92%
H: 9.26%
C: 8.8%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: -3.88%
H: 1.61%
C: -5.65%
symposium cell therapeutics
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 4.1%
H: 0.0%
C: -11.81%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.61%
H: 2.38%
C: -3.97%
rg6501 opregen innovation cell therapy results study
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 1.17%
H: 10.27%
C: 10.27%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: -5.38%
H: 17.89%
C: 4.88%
rg6501 opregen association research preclinical vision meeting results
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 3.16%
H: 0.0%
C: -0.5%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: -1.74%
business year update cell therapeutics financial results
GT County Commissioners Approve Parks Plan, Exploration of GO-REC Acquisition, Contentious Rule Changes – Traverse City Ticker
Published: 2024-01-04 (Crawled : 06:00) - spacfeed.com
FGH | $1.24 -5.7% 0.0% 0
|
Information
|
| O: 3.65%
H: 6.58%
C: -17.61%
SIF 4 | $3.015 -1.15% 0.0% 2K
|
Electronic Technology
|
| O: 3.47%
H: 0.41%
C: -4.16%
city
How to Buy a Distressed Tech Company: Key Areas of Focus – AllBusiness.com
Published: 2024-01-03 (Crawled : 05:00) - spacfeed.com
FGH | $1.24 -5.7% 0.0% 0
|
Information
|
| O: 3.65%
H: 6.58%
C: -17.61%
SIF 4 | $3.015 -1.15% 0.0% 2K
|
Electronic Technology
|
| O: 3.47%
H: 0.41%
C: -4.16%
Denver-Area VC Funding Declined 52%, But Life Sciences, Aerospace Offer Hope For Rebound
Published: 2024-01-03 (Crawled : 05:00) - spacfeed.com
FGH | $1.24 -5.7% 0.0% 0
|
Information
|
| O: 3.65%
H: 6.58%
C: -17.61%
AQU | $10.92 0.55% 1
|
n/a
|
| O: -0.09%
H: 9.11%
C: -0.09%
SIF 4 | $3.015 -1.15% 0.0% 2K
|
Electronic Technology
|
| O: 3.47%
H: 0.41%
C: -4.16%
life hope funding
BRBS EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BRBS
Published: 2023-12-06 (Crawled : 05:00) - prnewswire.com
DLO | $14.52 -4.47% -4.68% 1.2M
|
Information
|
| O: 0.48%
H: 1.48%
C: -0.3%
RBLX M | $35.34 -0.59% 0.0% 6.1M
|
|
| O: 0.3%
H: 1.64%
C: -2.03%
BRBS | $2.61 3.16% 0.0% 86K
|
Finance
|
| O: 0.0%
H: 0.0%
C: -1.47%
first deadline blue
WaveDancer Announces Reverse Stock Split
Published: 2023-10-17 (Crawled : 13:00) - globenewswire.com
WAVD | $2.02 -5.39% -5.69% 17K
|
Information
|
| O: -2.99%
H: 31.98%
C: 13.68%
ISDR | $11.52 -0.65% 0.11% 2.8K
|
Technology Services
|
| O: -0.99%
H: 2.66%
C: -0.7%
Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics
Published: 2023-09-06 (Crawled : 15:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 5.63%
H: 5.73%
C: -6.14%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.72%
H: 0.72%
C: -2.88%
partnership cell therapeutics
Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 5.63%
H: 5.73%
C: -6.14%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.72%
H: 0.72%
C: -2.88%
partnership cell therapeutics
Servotronics Announces Second Quarter 2023 Financial Results
Published: 2023-08-11 (Crawled : 04:00) - servotronics.com
SVT | $12.0 2.13% -2.08% 1.9K
|
Producer Manufacturing
|
| O: 0.0%
H: 0.18%
C: -2.26%
financial results
Servotronics Announces Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 21:00) - prnewswire.com
SVT | $12.0 2.13% -2.08% 1.9K
|
Producer Manufacturing
|
| O: 0.0%
H: 0.18%
C: -2.26%
financial results
Servotronics Announces First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 18:00) - servotronics.com
SVT | $12.0 2.13% -2.08% 1.9K
|
Producer Manufacturing
|
| O: -0.38%
H: 2.73%
C: -0.66%
financial results
Significant Amendments to CSE Policies come into force April 3, 2023 – McMillan LLP
Published: 2023-03-31 (Crawled : 22:00) - spacfeed.com
SLND 4 | $4.82 3.88% 0.0% 6.1K
|
n/a
| Email alert
Add to watchlist
NBY | $0.0824 -1.91% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BYOC | $0.0001 0.0% 500K
|
Information
| Email alert
Add to watchlist
Trump Indictment Could Put Merger Deal Back In Spotlight, Why … – Benzinga
Published: 2023-03-31 (Crawled : 22:00) - spacfeed.com
SLND 4 | $4.82 3.88% 0.0% 6.1K
|
n/a
| Email alert
Add to watchlist
NBY | $0.0824 -1.91% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BYOC | $0.0001 0.0% 500K
|
Information
| Email alert
Add to watchlist
back deal
BEYOND COMMERCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) – Marketscreener.com
Published: 2023-03-31 (Crawled : 22:00) - spacfeed.com
SLND 4 | $4.82 3.88% 0.0% 6.1K
|
n/a
| Email alert
Add to watchlist
NBY | $0.0824 -1.91% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
BYOC | $0.0001 0.0% 500K
|
Information
| Email alert
Add to watchlist
beyond financial results
Eterna Therapeutics Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
Published: 2023-03-20 (Crawled : 23:00) - globenewswire.com
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: 0.93%
H: 8.0%
C: 1.23%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.0%
H: 3.62%
C: 0.72%
business year therapeutics financial
Lineage Enters Into Option and License Agreement With Eterna Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
Published: 2023-02-22 (Crawled : 19:00) - biospace.com/
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: -1.34%
H: 2.36%
C: -3.02%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.0%
H: 3.97%
C: 0.79%
license therapeutics agreement
Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
Published: 2023-02-22 (Crawled : 13:20) - globenewswire.com
ERNA | $2.16 0.47% 0.46% 3.7K
|
Information
|
| O: -1.34%
H: 2.36%
C: -3.02%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.0%
H: 3.97%
C: 0.79%
license therapeutics agreement
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
NOV 4 | $18.75 1.35% -6.67% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.